David Medical(300314)
Search documents
戴维医疗(300314) - 关于董事会完成换届选举及聘任高级管理人员的公告
2025-11-03 11:24
证券代码:300314 证券简称:戴维医疗 公告编号:2025-076 宁波戴维医疗器械股份有限公司 关于董事会完成换届选举及聘任高级管理人员的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整, 没有虚假记载、误导性陈述或重大遗漏。 宁波戴维医疗器械股份有限公司(以下简称"公司")于2025年11月3 日召开了2025年第一次临时股东会,审议通过了关于董事会换届选举的相 关议案,选举产生了公司第六届董事会非职工代表董事成员,与同日召开 的职工代表大会选举产生的职工代表董事共同组成公司第六届董事会。同 日,公司召开了第六届董事会第一次会议,审议通过了关于选举公司第六 届董事会董事长和副董事长、董事会各专门委员会委员、聘任高级管理人 员等相关议案。现将相关情况公告如下: 一、公司第六届董事会组成情况 董事长:陈再宏先生 副董事长:陈再慰先生 二、第六届董事会各专门委员会组成情况 公司董事会下设战略委员会、审计委员会、提名委员会、薪酬与考核 委员会。董事会选举以下董事为第六届董事会各专门委员会委员,组成情 况如下: 战略委员会:陈再宏(主任委员)、奚盈盈、俞永伟 审计委员会:陈赛芳(主任委员)、朱亚清 ...
戴维医疗:关于全资子公司申报医疗器械注册获得受理的公告
Zheng Quan Ri Bao Zhi Sheng· 2025-10-31 11:09
Group 1 - The core point of the article is that David Medical announced the acquisition of a "Notice of Acceptance" for an electronic endoscope image processor from the Zhejiang Provincial Drug Administration [1] Group 2 - The product is developed by the company's wholly-owned subsidiary, Ningbo Weier Kaidi Medical Equipment Co., Ltd. [1]
戴维医疗:“电子内窥镜图像处理器”医疗器械注册获得受理
智通财经网· 2025-10-31 08:10
Core Viewpoint - David Medical (300314.SZ) announced that its wholly-owned subsidiary, Ningbo Weierkaidi Medical Equipment Co., Ltd., has recently obtained a "Notice of Acceptance" issued by the Zhejiang Provincial Drug Administration for its product, the "Electronic Endoscope Image Processor" [1] Group 1: Product Development - The Electronic Endoscope Image Processor developed by Weierkaidi is designed to be used with electronic endoscope products [1] - This processor serves as the "core control hub" of the entire diagnostic and treatment solution, featuring high-definition image acquisition, real-time signal conversion, and transmission capabilities [1] - It includes built-in algorithms for image enhancement and dynamic parameter adjustment, providing clear and stable visual support for clinical diagnosis [1] Group 2: Market Application - The Electronic Endoscope Image Processor is adaptable for minimally invasive diagnostic and treatment scenarios across various fields, including urology, gastroenterology, and respiratory medicine [1] - It meets the examination and treatment operational needs for different anatomical sites, enhancing the company's product portfolio in the minimally invasive medical field [1]
戴维医疗(300314.SZ):子公司申报医疗器械注册获得受理
Ge Long Hui A P P· 2025-10-31 08:06
Core Viewpoint - David Medical (300314.SZ) announced that its wholly-owned subsidiary, Ningbo Weier Kaidi Medical Equipment Co., Ltd. (referred to as "Weier Kaidi"), has recently obtained a "Notice of Acceptance" issued by the Zhejiang Provincial Drug Administration for an electronic endoscope image processor [1] Group 1 - The electronic endoscope image processor developed by Weier Kaidi is designed to be used in conjunction with electronic endoscope products [1] - This image processor serves as the "core control hub" of the entire diagnostic and treatment solution, featuring high-definition image acquisition, real-time signal conversion, and transmission capabilities [1] - The device includes built-in algorithms for image enhancement and dynamic parameter adjustment, providing clear and stable visual support for clinical diagnosis [1] Group 2 - The electronic endoscope image processor is adaptable for minimally invasive diagnostic and treatment scenarios across various fields, including urology, gastroenterology, and respiratory medicine [1] - It meets the examination and treatment operational needs for different anatomical sites, enhancing the company's product portfolio in the minimally invasive medical field [1]
戴维医疗(300314.SZ):“电子内窥镜图像处理器”医疗器械注册获得受理
智通财经网· 2025-10-31 08:02
Core Viewpoint - David Medical (300314.SZ) announced that its wholly-owned subsidiary, Ningbo Weierkaidi Medical Equipment Co., Ltd., has recently obtained a "Notice of Acceptance" issued by the Zhejiang Provincial Drug Administration for its product, the "Electronic Endoscope Image Processor" [1] Group 1 - The Electronic Endoscope Image Processor developed by Weierkaidi is designed to be used with electronic endoscope products [1] - This processor serves as the "core control hub" of the entire diagnostic and treatment solution, featuring high-definition image acquisition, real-time signal conversion and transmission capabilities [1] - It includes built-in algorithms for image enhancement and dynamic parameter adjustment, providing clear and stable visual support for clinical diagnosis [1] Group 2 - The Electronic Endoscope Image Processor is adaptable for minimally invasive diagnostic and treatment scenarios across various fields, including urology, gastroenterology, and respiratory medicine [1] - This product meets the examination and treatment operational needs for different anatomical sites, enhancing the company's product portfolio in the minimally invasive medical field [1]
戴维医疗(300314) - 关于全资子公司申报医疗器械注册获得受理的公告
2025-10-31 07:48
证券代码:300314 证券简称:戴维医疗 公告编号:2025-073 特此公告。 宁波戴维医疗器械股份有限公司 宁波戴维医疗器械股份有限公司(以下简称"公司")全资子公司宁波 维尔凯迪医疗器械有限公司(以下简称"维尔凯迪")于近日取得由浙江省 药品监督管理局颁发的1项《受理通知书》,受理号为:械受20254034843。 具体情况如下: | | 电子内窥镜图像处理 器 | | 用于在内窥镜诊断和/或治疗/手术中与电 子内窥镜连接,有效地在监视器上显示内窥 | | --- | --- | --- | --- | | | | II 类 | | | 序号 1 | 产品名称 | 注册分类 | 临床用途 镜观察人体体腔的视场区域的图像。 | 维尔凯迪开发的电子内窥镜图像处理器配套开发的电子内窥镜产品使用。 电子内窥镜图像处理器作为整套诊疗方案的 "核心控制中枢",不仅具备高 清图像采集、实时信号转化与传输功能,还可通过内置算法实现图像增强、 参数动态调节等辅助诊疗功能,为临床诊断提供清晰、稳定的视觉支持。电 子内窥镜图像处理器可适配泌尿、消化、呼吸等多领域电子内窥镜微创诊疗 场景,满足不同解剖部位的检查与治疗操作需求 ...
戴维医疗的前世今生:营收3.93亿低于行业平均,净利润7261.78万高于中位数
Xin Lang Cai Jing· 2025-10-31 00:22
Core Viewpoint - David Medical is a leading company in the infant care equipment sector in China, with strong technological advantages in obstetric and pediatric care equipment development [1] Group 1: Business Performance - In Q3 2025, David Medical reported revenue of 393 million yuan, ranking 26th among 42 companies in the industry, significantly lower than the top company, Mindray Medical, which had 25.834 billion yuan [2] - The main business segments include obstetric and pediatric care equipment, generating 130 million yuan (51.93% of total revenue), and minimally invasive surgical instruments, generating 115 million yuan (45.88%) [2] - The net profit for the same period was 72.6178 million yuan, ranking 21st in the industry, which is considerably lower than the leading companies [2] Group 2: Financial Ratios - As of Q3 2025, David Medical's debt-to-asset ratio was 15.59%, an increase from 12.25% year-on-year, but still below the industry average of 27.21%, indicating strong solvency [3] - The gross profit margin was 56.43%, slightly down from 56.78% year-on-year, yet higher than the industry average of 48.67%, reflecting robust profitability [3] Group 3: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 2.42% to 20,300, while the average number of circulating A-shares held per shareholder increased by 2.48% to 7,081.91 [5] - New significant shareholders include Medical Device ETF and Baodao Jiuhang Mixed A, while Jin Yuan Shun An Yuan Qi Flexible Allocation Mixed and Yuanxin Yongfeng Ju You A exited the top ten circulating shareholders list [5]
10月30日这些公告有看头
Di Yi Cai Jing· 2025-10-30 14:08
Major Events - Vanke A's largest shareholder, Shenzhen Metro Group, plans to provide a loan of up to 2.2 billion yuan to the company for repaying bond principal and interest, with a term of no more than 3 years and an interest rate reduced by 66 basis points from the 1-year LPR [2] - ST Chuangxing's chairman, Liu Peng, has been arrested on criminal charges, but the company states that this matter is unrelated to its operations, and the board is functioning normally [2] - Shannon Chip's chairman, Fan Yongwu, resigned for personal reasons, and Huang Zewei has been elected as the new chairman, holding over 10% of the company's shares [3] - China Coal Energy has invested 1 billion yuan in a state-owned strategic emerging industry fund, which has a total size of 51 billion yuan, aimed at expanding its industrial cooperation ecosystem [4] - Da'an Gene's board has authorized management to sell part of its stock assets, with a limit of 1% through centralized bidding and 2% through block trading [5][6] - Kaineng Health plans to acquire several subsidiaries from Yuaneng Group to strengthen its investment in the cell industry [6] - David Medical's subsidiary has received a medical device registration certificate for a disposable lung nodule positioning puncture needle [7] Financial Performance - Sairus reported a Q3 net profit of 2.371 billion yuan, a decrease of 1.74% year-on-year, with a revenue of 48.133 billion yuan, up 15.75% [8] - Upwind New Materials achieved a Q3 net profit of 30.6473 million yuan, a 49.66% increase year-on-year, with revenue of 496 million yuan, up 23.73% [9] - Youzu Network's Q3 net profit surged by 4466.74% to 26.1999 million yuan, with revenue of 331 million yuan, up 11.99% [10] - Zhongji Xuchuang's Q3 net profit increased by 124.98% to 3.137 billion yuan, with revenue of 10.216 billion yuan, up 56.83% [11] - SAIC Group's Q3 net profit reached 2.083 billion yuan, a 644.88% increase, with revenue of 169.403 billion yuan, up 16.19% [12] - China Life's Q3 net profit was 126.873 billion yuan, a 91.5% increase, with revenue of 298.66 billion yuan, up 54.8% [13] - Pingtan Development's Q3 net profit grew by 1970.63% to 16.1449 million yuan, with revenue of 287 million yuan, up 11.78% [14] - Huatai Securities reported a Q3 net profit of 5.183 billion yuan, a decrease of 28.11%, with revenue of 10.909 billion yuan, down 6.94% [15] - Yanzhou Coal's Q3 net profit was 2.288 billion yuan, down 36.60%, with revenue of 38.259 billion yuan, down 0.26% [16] - Dongwu Securities' Q3 net profit increased by 50.56% to 1.003 billion yuan, with revenue of 2.846 billion yuan, up 38.39% [17] - Dongxing Securities' Q3 net profit surged by 112.67% to 780 million yuan, with revenue of 1.361 billion yuan, up 35.79% [18] - CMB Securities reported a Q3 net profit of 3.686 billion yuan, a 53.45% increase, with revenue of 7.723 billion yuan, up 64.89% [19] - Agricultural Bank's Q3 net profit was 81.349 billion yuan, up 3.66%, with revenue of 1809.81 billion yuan, up 4.30% [20] - Industrial and Commercial Bank's Q3 net profit reached 101.805 billion yuan, up 3.29%, with revenue of 2018.86 billion yuan, up 2.42% [21] - Shenghe Resources reported a Q3 net profit increase of 748.07% [22] - Ingrity Media's Q3 net profit was 442.85 million yuan, up 167.91%, with revenue of 1.919 billion yuan, up 29.70% [23] - China Duty Free's Q3 net profit decreased by 28.94% to 452 million yuan, with revenue of 11.711 billion yuan, down 0.38% [24] - Luzhou Laojiao's Q3 net profit was 3.099 billion yuan, down 13.07%, with revenue of 6.674 billion yuan, down 9.80% [25] - Longi Green Energy reported a Q3 net loss of 834 million yuan, with revenue of 18.101 billion yuan, down 9.78% [26] - New Hope's Q3 net profit was 512.55 million yuan, down 99.63%, with revenue of 28.879 billion yuan, up 4.51% [27] - Wealth Trend's Q3 net profit increased by 76.93% to 77.1855 million yuan, with revenue of 65.3534 million yuan, up 4.31% [28] - Hunan Silver's Q3 net profit was 96.3611 million yuan, up 47.51%, with revenue of 4.065 billion yuan, up 98.68% [29] - Spring Airlines' Q3 net profit decreased by 6.17% to 1.167 billion yuan, with revenue of 6.469 billion yuan, up 6.01% [30] - Litong Electronics reported a Q3 net profit of 165 million yuan, up 1432.90%, with revenue of 946 million yuan, up 57.09% [31] - Baosteel's Q3 net profit increased by 130.31% to 3.081 billion yuan, with revenue of 81.064 billion yuan, up 1.83% [32] - Giant Star Technology's Q3 net profit was 882 million yuan, up 18.96%, with revenue of 4.129 billion yuan, down 5.80% [33] - Wanda Film's Q3 net profit increased by 319.92% year-on-year [34] - COSCO Shipping's Q3 net profit decreased by 29% [35] - PetroChina's Q3 net profit was 42.29 billion yuan, down 3.9%, with revenue of 719.16 billion yuan, up 2.3% [36] - JA Solar reported a Q3 net loss of 3.553 billion yuan [37] - BOE Technology's Q3 net profit was 1.355 billion yuan, up 32.07%, with revenue of 53.270 billion yuan, up 5.81% [38] - BYD's Q3 net profit was 7.823 billion yuan, down 32.60%, with revenue of 194.985 billion yuan, down 3.05% [39] - Guotai Junan's Q3 net profit increased by 40.60% to 6.337 billion yuan, with revenue of 22.019 billion yuan, up 136.00% [40] - Jianghuai Automobile reported a Q3 net loss of 661 million yuan, with revenue of 11.513 billion yuan, up 5.54% [41] - Zhezhong Co. reported a Q3 net profit of 206 million yuan, up 5282.88%, with revenue of 232 million yuan, down 21.33% [42] - Yonghui Supermarket reported a Q3 net loss of 469 million yuan, with revenue of 12.486 billion yuan, down 25.55% [43] Shareholding Changes - Ruisheng Intelligent's shareholder plans to reduce its stake by up to 3% [44] - SF Holding adjusted its share repurchase plan to a total amount of not less than 1.5 billion yuan and not more than 3 billion yuan [45] - Changying Precision adjusted its share repurchase price limit to 50 yuan per share [46] Major Contracts - Trina Solar signed a sales contract for over 1 GWh of energy storage products with a European customer [47]
10月30日这些公告有看头
第一财经· 2025-10-30 14:04
Major Events - Vanke A's largest shareholder, Shenzhen Metro Group, plans to provide a loan of up to 2.2 billion yuan to the company for repaying bond principal and interest, with a term of no more than 3 years and an interest rate reduced by 66 basis points from the 1-year LPR [4] - *ST Chuangxing's chairman, Liu Peng, has been arrested for suspected criminal activities, but the company's operations remain normal under the management of the executive team [5] - Shannon Chip's chairman, Huang Zewei, has been elected following the resignation of the previous chairman, Fan Yongwu [6][7] - China Coal Energy has invested 1 billion yuan in a state-owned strategic emerging industry fund, which has a total size of 51 billion yuan, aimed at expanding its industrial cooperation ecosystem [8] - Da'an Gene's board has authorized management to sell part of its stock assets, with a limit of 1% through centralized bidding and 2% through block trading [9] - Kaineng Health plans to acquire several subsidiaries of Yuaneng Group to strengthen its investment in the cell industry, aiming to create a second growth curve [10] - David Medical's subsidiary has received a medical device registration certificate for a disposable lung nodule positioning puncture needle [11] Performance Overview - Saisir reported a Q3 net profit of 2.371 billion yuan, a year-on-year decrease of 1.74%, with a revenue of 48.133 billion yuan, up 15.75% [12][13] - Upwind New Materials achieved a Q3 net profit of 30.6473 million yuan, a year-on-year increase of 49.66% [14] - Youzu Network's Q3 net profit surged by 4466.74% to 26.1999 million yuan [15] - Zhongji Xuchuang's Q3 net profit increased by 124.98% to 3.137 billion yuan [16] - SAIC Motor's Q3 net profit reached 2.083 billion yuan, up 644.88% [17] - China Life's Q3 net profit was 126.873 billion yuan, a year-on-year increase of 91.5% [18] - Pingtan Development's Q3 net profit grew by 1970.63% to 16.1449 million yuan [19] - Huatai Securities reported a Q3 net profit of 5.183 billion yuan, down 28.11% [20] - Yanzhou Coal's Q3 net profit decreased by 36.60% to 2.288 billion yuan [21] - Dongwu Securities' Q3 net profit increased by 50.56% to 1.003 billion yuan [22] - Dongxing Securities' Q3 net profit surged by 112.67% to 780 million yuan [23] -招商证券's Q3 net profit increased by 53.45% to 3.686 billion yuan [24] - Agricultural Bank's Q3 net profit was 81.349 billion yuan, up 3.66% [25] - Industrial and Commercial Bank's Q3 net profit reached 101.805 billion yuan, a year-on-year increase of 3.29% [26] - Shenghe Resources reported a Q3 net profit growth of 748.07% [28] -引力传媒's Q3 net profit increased by 167.91% to 442.85 million yuan [29] - China Duty Free's Q3 net profit decreased by 28.94% to 452 million yuan [30] - Luzhou Laojiao's Q3 net profit decreased by 13.07% to 3.099 billion yuan [31] - Everbright Securities' Q3 net profit increased by 65.88% to 999.5 million yuan [32] - Gujing Gongjiu's Q3 net profit decreased by 74.56% to 299 million yuan [33] - Longi Green Energy reported a Q3 net loss of 834 million yuan [34] - New Hope's Q3 net profit decreased by 99.63% to 512.55 million yuan [35] - Wealth Trend's Q3 net profit increased by 76.93% to 77.1855 million yuan [36] - Hunan Silver's Q3 net profit increased by 47.51% to 96.3611 million yuan [37] - Spring Airlines' Q3 net profit decreased by 6.17% to 1.167 billion yuan [38] - Litong Electronics' Q3 net profit surged by 1432.90% to 165 million yuan [39] - Baosteel's Q3 net profit increased by 130.31% to 3.081 billion yuan [40] - Juxing Technology's Q3 net profit increased by 18.96% to 882 million yuan [42] - Wanda Film's Q3 net profit increased by 319.92% [43] - COSCO Shipping's Q3 net profit decreased by 29% [44] - China Petroleum's Q3 net profit was 42.29 billion yuan, down 3.9% [45] - JA Solar reported a Q3 net loss of 3.553 billion yuan [46] - BOE Technology's Q3 net profit increased by 32.07% to 1.355 billion yuan [47] - BYD's Q3 net profit decreased by 32.60% to 7.823 billion yuan [48] - Guotai Junan's Q3 net profit increased by 40.60% to 6.337 billion yuan [50] - Jianghuai Automobile reported a Q3 net loss of 661 million yuan [51] - Zhezhong Co.'s Q3 net profit increased by 5282.88% to 206 million yuan [52] - Yonghui Supermarket reported a Q3 net loss of 469 million yuan [53] Shareholding Changes - Ruisheng Intelligent's shareholder plans to reduce its stake by up to 3% [54] Share Buybacks - SF Holding has adjusted its share buyback plan to a total amount of not less than 1.5 billion yuan and not more than 3 billion yuan [55][56] - Changying Precision has raised its share buyback price limit to 50 yuan per share [57] Major Contracts - Trina Solar signed a sales contract for over 1 GWh of energy storage products with a European customer [58]
戴维医疗:全资子公司“一次性使用肺结节定位穿刺针”取得注册证
Sou Hu Cai Jing· 2025-10-30 09:12
Group 1 - David Medical (SZ 300314) announced on October 30 that its wholly-owned subsidiary, Ningbo Weierkaidi Medical Devices Co., Ltd., received a medical device registration certificate from the Zhejiang Provincial Drug Administration for a product named "Disposable Lung Nodule Localization Puncture Needle" [1] - For the fiscal year 2024, David Medical's revenue composition is projected to be 98.08% from the medical device manufacturing sector and 1.92% from other businesses [1] - As of the report date, David Medical has a market capitalization of 3.8 billion yuan [1]